BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5781897)

  • 1. Fatty acid composition of serum and tissue lipids in benign and malignant gynecologic disease.
    De Alvarez RR; Castellanos H; O'Leary DK; Jahed F
    Am J Obstet Gynecol; 1969 May; 104(2):230-46. PubMed ID: 5781897
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty acid composition of serum lipids in pregnancy and gynecologic cancer.
    De Alvarez RR; Goodell BW; Zighelboim I
    Am J Obstet Gynecol; 1967 Feb; 97(3):419-42. PubMed ID: 6016502
    [No Abstract]   [Full Text] [Related]  

  • 3. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
    Puistola U; Risteli L; Risteli J; Kauppila A
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
    Wu M; Gunning W; Ratnam M
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S; Mesa-Tejada R; Husami N; Bennett S; Richart RM; Fenogolio CM
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract]   [Full Text] [Related]  

  • 6. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions.
    Khorram O; Garthwaite M; Grosen E; Golos T
    Fertil Steril; 2001 Jan; 75(1):174-9. PubMed ID: 11163834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids and phospholipids in the uterine cells in normal and pathological conditions].
    Moggian G; Barboni F; Spaletta M
    Minerva Ginecol; 1971 Mar; 23(6):301-3. PubMed ID: 5566182
    [No Abstract]   [Full Text] [Related]  

  • 9. [State of the hemostasis system in patients with benign tumors of the uterus and adnexa uteri in pre- and postoperative periods].
    Savchenko VF
    Akush Ginekol (Mosk); 1983 Dec; (12):67-70. PubMed ID: 6666829
    [No Abstract]   [Full Text] [Related]  

  • 10. CA 125 in the serum and tissue of patients with gynecological disease.
    Fuith LC; Daxenbichler G; Dapunt O
    Arch Gynecol Obstet; 1987; 241(3):157-64. PubMed ID: 3481250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
    Inoue S; Shibata S; Okumura A; Tanaka T; Onitsuka Y; Yoshimura T; Aiko A; Ikuta Y; Fukuma K; Matsuura K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):499-504. PubMed ID: 3923940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmafibronectin in case of tumors of the female genital system].
    Tatra G; Nasr F
    Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper and zinc concentrations in normal and malignant tissues of ovary, uterus and cervix.
    Jendryczko A; Drózdz M; Tomala J; Magner K; Dzieciuchowicz L
    Ginekol Pol; 1985 Nov; 56(11):677-81. PubMed ID: 4092997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
    Zhang W; Wang P; Zhao Y
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE CLINICAL ASPECTS OF FEMALE GENITAL TUBERCULOSIS TODAY.
    RIPPMANN ET
    Gynaecologia; 1964; 157():77-94. PubMed ID: 14124966
    [No Abstract]   [Full Text] [Related]  

  • 18. Ectopic human chorionic gonadotropin: gynecological tumors and nonmalignant conditions.
    Carenza L; Gregorio R; Mocci C; Moro M; Pala A
    Gynecol Oncol; 1980 Aug; 10(1):32-8. PubMed ID: 7399328
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetics of gynecologic neoplasms.
    Wakonig-Vaartaja T; Auersperg N
    Clin Obstet Gynecol; 1970 Dec; 13(4):813-30. PubMed ID: 4930554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood group frequencies in obstetric and gynecologic diseases].
    Balika IuD; Trepakov EA
    Akush Ginekol (Mosk); 1977 Dec; (12):45-7. PubMed ID: 564616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.